168 related articles for article (PubMed ID: 38166916)
21. Integrating plasma metabolomics and gut microbiome to reveal the mechanisms of Huangqi Guizhi Wuwu Decoction intervene diabetic peripheral neuropathy.
Zhang K; Peng P; Huang J; Chen M; Liu F; Zhu C; Lu Q; Wang M; Lin C
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117301. PubMed ID: 37820997
[TBL] [Abstract][Full Text] [Related]
22. Study on efficacy and safety of Huangqi Guizhi Wuwu decoction treatment for oxaliplatin induced peripheral neurotoxicity: A protocol for a randomized, controlled, double-blind, multicenter trial.
Wei XM; Chen XF; Shu P; Jiang ZW; Wu XY; Zou X; Chen K; Shen B; Hu WW; Lu W; Shen WX; Li L; Wang JY; Zhao FJ; Yin QF; Cheng HB; Gu YH
Medicine (Baltimore); 2020 May; 99(22):e19923. PubMed ID: 32481364
[TBL] [Abstract][Full Text] [Related]
23. Huangqi Guizhi Wuwu Decoction can prevent and treat oxaliplatin-induced neuropathic pain by TNFα/IL-1β/IL-6/MAPK/NF-kB pathway.
Li M; Li Z; Ma X; Jin S; Cao Y; Wang X; Zhao J; Wang J; Wang X; Xu J
Aging (Albany NY); 2022 Jun; 14(12):5013-5022. PubMed ID: 35759577
[TBL] [Abstract][Full Text] [Related]
24. Integrated serum pharmacochemistry and network pharmacological analysis used to explore possible anti-rheumatoid arthritis mechanisms of the Shentong-Zhuyu decoction.
Wang L; Pu X; Nie X; Wang D; Jiang H; Chen Y; Pang L; Wang S; Wang X; Xu Z; Fu C; Lin D; Zhang J
J Ethnopharmacol; 2021 Jun; 273():113988. PubMed ID: 33667569
[TBL] [Abstract][Full Text] [Related]
25. Network Pharmacology Analysis and Experimental Validation to Investigate the Mechanism of Total Flavonoids of Rhizoma Drynariae in Treating Rheumatoid Arthritis.
Chen GY; Luo J; Liu Y; Yu XB; Liu XY; Tao QW
Drug Des Devel Ther; 2022; 16():1743-1766. PubMed ID: 35702063
[TBL] [Abstract][Full Text] [Related]
26. Huangqi Guizhi Wuwu decoction alleviates oxaliplatin-induced peripheral neuropathy via the gut-peripheral nerve axis.
Zhang Z; Ye J; Liu X; Zhao W; Zhao B; Gao X; Lan H; Wu Y; Yang Y; Cao P
Chin Med; 2023 Sep; 18(1):114. PubMed ID: 37679804
[TBL] [Abstract][Full Text] [Related]
27. [Mechanism of Sijunzi Decoction in treatment of Alzheimer's disease based on UPLC-Q-TOF-MS, network pharmacology, and experimental verification].
Cai KZ; Zheng Q; Zhu XD; Wei SF; Wu MQ; Xiong H; Zhao HT
Zhongguo Zhong Yao Za Zhi; 2023 Mar; 48(6):1620-1631. PubMed ID: 37005850
[TBL] [Abstract][Full Text] [Related]
28. Exploration of the mechanism by which Huangqi Guizhi Wuwu decoction inhibits Lps-induced inflammation by regulating macrophage polarization based on network pharmacology.
Wang S; Ji T; Wang L; Qu Y; Wang X; Wang W; Lv M; Wang Y; Li X; Jiang P
BMC Complement Med Ther; 2023 Jan; 23(1):8. PubMed ID: 36624435
[TBL] [Abstract][Full Text] [Related]
29. Systems Pharmacology Dissection of Multiscale Mechanisms of Action for Herbal Medicines in Treating Rheumatoid Arthritis.
Wang J; Li Y; Yang Y; Du J; Zhao M; Lin F; Zhang S; Wang B
Mol Pharm; 2017 Sep; 14(9):3201-3217. PubMed ID: 28771010
[TBL] [Abstract][Full Text] [Related]
30. Huangqi Guizhi Wuwu decoction promotes M2 microglia polarization and synaptic plasticity via Sirt1/NF-κB/NLRP3 pathway in MCAO rats.
Ou Z; Zhao M; Xu Y; Wu Y; Qin L; Fang L; Xu H; Chen J
Aging (Albany NY); 2023 Aug; 15(19):10031-10056. PubMed ID: 37650573
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
32. A Novel Drug Combination of Mangiferin and Cinnamic Acid Alleviates Rheumatoid Arthritis by Inhibiting TLR4/NFκB/NLRP3 Activation-Induced Pyroptosis.
Li W; Wang K; Liu Y; Wu H; He Y; Li C; Wang Q; Su X; Yan S; Su W; Zhang Y; Lin N
Front Immunol; 2022; 13():912933. PubMed ID: 35799788
[TBL] [Abstract][Full Text] [Related]
33. [Anti-rheumatoid arthritis mechanism of Sophorae Tonkinesis Radix et Rhizoma based on network pharmacology and experimental verification].
Zhu PP; Qi MZ; Yang JH; Tao XY; Lin N; Su XH; Kong XY
Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(19):5327-5335. PubMed ID: 36472040
[TBL] [Abstract][Full Text] [Related]
34. Comparison of IDA, SWATH, and MS
Fan Z; Guan J; Tang X; Ge S; Shen G; Li L; Zhu H; Feng B
Biomed Chromatogr; 2023 Oct; 37(10):e5715. PubMed ID: 37607558
[TBL] [Abstract][Full Text] [Related]
35. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
[TBL] [Abstract][Full Text] [Related]
37. Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia.
Ye M; Liu G; Yang Y; Yang H; Ren J; Chen W; Gao Z
Sci Rep; 2023 Oct; 13(1):17385. PubMed ID: 37833363
[TBL] [Abstract][Full Text] [Related]
38. [
Cui Y; Mi J; Feng Y; Li L; Wang Y; Hu J; Wang H
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):649-657. PubMed ID: 35673907
[TBL] [Abstract][Full Text] [Related]
39. Network Pharmacology and Molecular Docking Study of the Chinese Miao Medicine Sidaxue in the Treatment of Rheumatoid Arthritis.
Wu N; Yuan T; Yin Z; Yuan X; Sun J; Wu Z; Zhang Q; Redshaw C; Yang S; Dai X
Drug Des Devel Ther; 2022; 16():435-466. PubMed ID: 35221674
[TBL] [Abstract][Full Text] [Related]
40. Study on the mechanism of Gualou Xiebai Guizhi decoction (GLXBGZD) in the treatment of coronary heart disease based on network pharmacology.
Teng C; Wang Y; Pang S; Wei X; Liu X
Medicine (Baltimore); 2022 Jul; 101(29):e29490. PubMed ID: 35866783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
